Kalliopi Kotsa - Concepedia

Author

Kalliopi Kotsa

Aristotle University of Thessaloniki ORCID

Also Known As

G Constantine, K Kotsa, K. Kotsa, K.D. KOTSA, KALLIOPI KOTSA, Kalliopi D Kotsa, Kalliopi Kotsa, Kotsa K, Kotsa, K., Maria Grammatiki

262

Publications

6.3K

Citations

H-Index

118

Concepts

All Affiliations

Aristotle University of Thessaloniki AHEPA University Hospital National and Kapodistrian University of Athens Kingston University University of Ioannina

About

Kalliopi Kotsa is an author at Aristotle University of Thessaloniki specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	32	3.1K
2	Public Health	12	12	345
3	Health Sciences	10	10	341
4	Allergy	1	1	65
5	Anesthesia	1	1	11

Kalliopi Kotsa

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Stefano Del Prato, Steven E. Kahn, Imre Pávó, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	586
A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism Kalliopi Kotsa, P. F. Watson, Anthony P. Weetman Clinical Endocrinology	1997	257
Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome Kalliopi Kotsa, Maria P. Yavropoulou, Olympia E. Anastasiou, Fertility and Sterility Metabolic SyndromeGlucose MetabolismHealth SciencesMetabolic DisorderPhysiology	2008	136
No Association between a Thyrotropin Receptor Gene Polymorphism and Graves' Disease in the Female Population Kalliopi Kotsa, P. F. Watson, Anthony P. Weetman Thyroid Allelic VariantAllergyAutoimmune DiseasePcr AmplificationGenetics	1997	65
Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial Eirini Papadopoulou, Charalampos Loutradis, Glykeria Tzatzagou, Journal of Hypertension	2020	63
Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities Ioannis Ogrotis, Theocharis Koufakis, Kalliopi Kotsa Medicina NutritionWorldwide IncidenceObesityMetabolic SyndromeType 1	2023	60
The role of telenursing in the management of Diabetes Type 1: A randomized controlled trial Konstantia Kotsani, Vasiliki Antonopoulou, Aikaterini Kountouri, International Journal of Nursing Studies Diabetes ManagementInsulin ManagementDiabetesDiabetes MellitusTelecare	2018	55
Lipoprotein profile, glycemic control and physical fitness after strength and aerobic training in post-menopausal women with type 2 diabetes Zois E. Christos, Savvas P. Tokmakidis, Konstantinos Volaklis, European Journal of Applied Physiology Metabolic SyndromeDiabetes ManagementKinesiologyHealth SciencesPhysical Fitness	2009	54
VDR TaqI is associated with obesity in the Greek population Yiannis Vasilopoulos, Theologia Sarafidou, Kalliopi Kotsa, Gene ObesityMetabolic SyndromeChildhood ObesityMetabolic DisorderVdr Taqi	2012	51

Page 1